Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$8,504,172
+$1,102,337 QoQ
Shares Held
33,795
-0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.35%
of 13F equity value
Holder Rank
#1,008
of 4,153 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026New Hampshire Trust holds $23,591,468 across 9 Drug Manufacturers - General names. ABBV ranks #1 (36.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
33,795 | $8,504,172 | |
| 2 | MRK |
Merck & Co., Inc.
|
54,175 | $6,961,487 | |
| 3 | JNJ |
Johnson & Johnson
|
15,285 | $3,881,930 | |
| 4 | NVS |
Novartis AG
|
7,170 | $1,123,681 | |
| 5 | LLY |
ELI LILLY & Co
|
933 | $1,119,067 | |
| 6 | AMGN |
Amgen Inc
|
2,237 | $810,062 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,927 | $571,992 | |
| 8 | PFE |
Pfizer Inc
|
16,564 | $398,861 |
All Filings in ABBV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,504,172 | 33,795 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $7,401,835 | 34,033 | Shares | Defined | 2026-04-20 | |
| 2025-12-31 | $7,820,754 | 34,228 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $8,490,339 | 36,669 | Shares | Defined | 2025-10-16 | |
| 2025-06-30 | $6,684,361 | 36,011 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $7,385,159 | 35,248 | Shares | Defined | 2025-04-08 | |
| 2024-12-31 | $6,435,227 | 36,214 | Shares | Defined | 2025-01-16 | |
| 2024-09-30 | $7,131,989 | 36,115 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $6,228,747 | 36,315 | Shares | Defined | 2024-07-15 | |
| 2024-03-31 | $6,620,609 | 36,357 | Shares | Defined | 2024-04-09 | |
| 2023-12-31 | $5,465,015 | 35,265 | Shares | Defined | 2024-01-12 | |
| 2023-09-30 | $5,397,460 | 36,210 | Shares | Defined | 2023-10-17 | |
| 2023-06-30 | $5,023,945 | 37,289 | Shares | Defined | 2023-07-11 | |
| 2023-03-31 | $5,919,957 | 37,146 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $6,226,509 | 38,528 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||